Predictive Oncology Inc.
13F holders, Q3 2024 (September 30)15holders −1
3new positions
4sold out
$0.78avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Predictive Oncology Inc. in their 13F filings, down 1 from Q2 2024. 3 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($56K), Geode Capital Management, LLC ($41K) and Susquehanna International Group, LLP ($12K).
- Company
- Predictive Oncology Inc.
- CUSIP
- 74039M309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $18K |
| Exits | 4 | $99K |
All 13F filers, Q2 2024 → Q3 2024: 39,040 shares bought and 125,681 shares sold, net −86,641 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Vanguard Group Inc. | 0.00% | No change | 71,307 | $56K |
| Geode Capital Management, LLC | 0.00% | Add +26.7% | 51,868 | $41K |
| Susquehanna International Group, LLP | 0.00% | Add +9.9% | 14,948 | $12K |
| State Street Corp. | 0.00% | No change | 13,837 | $11K |
| Two Sigma Investments, LP | 0.00% | New | 12,560 | $10K |
| Carnegie Mellon University | 0.01% | No change | 10,358 | $8K |
| Csenge Advisory Group | 0.00% | New | 13,000 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +19.0% | 7,099 | $6K |
| UBS Group AG | 0.00% | Reduce -86.2% | 4,908 | $4K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $788 |
| Osaic Holdings, Inc. | 0.00% | No change | 425 | $334 |
| PSI Advisors, LLC | 0.00% | No change | 399 | $314 |
| National Bank of Canada | 0.00% | No change | 100 | $79 |
| Bank of America Corp. | 0.00% | Add +54.5% | 51 | $40 |
| Royal Bank of Canada | 0.00% | New | 50 | $0 |
"% of holder's portfolio" is PREDICTIVE ONCOLOGY INC's weight in each manager's 13F, not the share of Predictive Oncology Inc. the manager owns.